The top five venture deals for 2024 raised a total of $358.5 million, nearly $125 million more than last year.

President-elect Donald Trump’s proposed tariffs on good from Canada, Mexico and China could raise costs, disrupt supply ...

J.P. Morgan has once again picked Boston Scientific (NYSE:BSX) and Intuitive Surgical (NASDAQ:ISRG) as its top large-cap ...

The Impact of M&A in MedTech, Webinar Hosted by MedWorld Advisors with Today's Medical Developments ...

Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public ...

The integration of IoT and AI is not just a technological advancement—it’s a shift toward patient-centric care.

Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.

In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...

Last December, the FDA published its final guidance on predetermined change control plans, or PCCPs, with recommendations to ...

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

China's National Medical Products Administration (NMPA) has approved the launch of Genesis Medtech’s iReach Omnia, a powered ...

Medical technology Association of India (MTaI) is gearing up to host its flagship event, MedTekon 2025, on 30th January 2025 ...